Home Health Care News September 21, 2021
Andrew Donlan

Walgreens Boots Alliance (Nasdaq: WBA) plans to invest $970 million in Shields Health Solutions, which aids both hospitals and health systems with specialty pharmacy services.

It’s another major move for Walgreens, which is trying to position itself as an all-encompassing health care behemoth prepared for the sector’s near- and long-term trends.

The deal, which is set to close in February of 2022, would give Walgreens a 71% stake in the Massachusetts-based Shields, with an option to acquire the remaining portion of the company thereafter.

Walgreens first took interest in Shields when it made a minority investment in the company in 2019.

Similar to its $1 billion investment in the value-based primary care provider VillageMD in 2020, the investment in Shields...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Investments, Pharma, Pharma / Biotech, Provider, Trends
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
Scientists reveal new method that could reduce waste from drug manufacturing
ETH develops AI algorithm for drug discovery based on 3D protein surface

Share This Article